GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Azbil Corp (FRA:YMK) » Definitions » Valuation Rank

Azbil (FRA:YMK) Valuation Rank


View and export this data going back to 1961. Start your Free Trial

What is Azbil Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Azbil Valuation Rank Related Terms

Thank you for viewing the detailed overview of Azbil's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Azbil Business Description

Traded in Other Exchanges
Address
2-7-3 Marunouchi, Chiyoda-ku, Tokyo, JPN, 100-6419
Azbil Corp is a Japan-based company that primarily operates through three segments. The building automation segment designs and manufactures building automation products, which include application software, controllers, valves, sensors, and others. This segment also provides engineering, maintenance, energy-saving, and facility management services. The advanced automation segment provides products, solutions, and engineering and maintenance services to help plants improve efficiency. The life automation segment is involved in utilities serviced, pharmaceutical and medical fields, life sciences research, and others. The company generates the majority of its revenue from the Japanese domestic market.